Loading...
NPI 1609908474 · Topeka, KS · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Cotton-o'neil Clinic Revocable Trust is a clinical medical laboratory provider located in Topeka, Kansas. This profile covers 291 Medicare and 166 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Cotton-o'neil Clinic Revocable Trust |
| Address | 901 Sw Garfield Ave |
| City | Topeka |
| State | KS |
| ZIP | 66606 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 9, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $6.8M |
| Medicare | $3.6M |
The provider’s claim mix shows a full-service outpatient clinical laboratory footprint: high-volume routine chemistry and hematology codes such as 80053 (CMP), 84443 (TSH), 85025 (CBC) appear prominently on the Medicare and Medicaid lists alongside molecular and infectious-disease assays like 87635 and U0003. This combination indicates the operation processes large volumes of common diagnostic panels while also supporting nucleic-acid testing workflows, consistent with a lab that handles both routine testing and high-throughput infectious-disease assays.
Medicare revenue is concentrated in a few core panels: 80053 ($453.9K, 16.3%), 84443 ($414.4K, 14.9%), and 85025 ($324K, 11.6%) — the precomputed top-3 share is 42.7% of Medicare revenue. That concentration implies that a relatively small set of common chemistry/hematology tests account for nearly half of the $3.6M billed to Medicare, making those panels critical to the provider’s Medicare book.
Medicaid billing shows a different revenue concentration profile driven by molecular infectious testing and core panels: U0003 ($952.6K, 17.6%), 80053 ($399.4K, 7.4%), and 87491 ($384.6K, 7.1%), with the top three accounting for a precomputed 32.0% of Medicaid revenue. The prominence of U0003 and other SARS-CoV-2/NAAT codes on the Medicaid side signals that COVID and other molecular testing are major revenue drivers within the $6.8M Medicaid book.
The payer mix favors Medicaid in scale: reported lifetime Medicaid revenue is $6.8M versus $3.6M from Medicare, so Medicaid is the larger single public payer for this entity. This imbalance suggests the lab derives greater overall volume or higher-reimbursing work from state-covered populations and public-health testing programs relative to its Medicare business.
On Medicare competitive standing the provider is a national high-volume performer for common lab services — multiple top codes rank at or near the top nationally (for example, 80053 ranks #73 of 26416 and is described as notably above typical national volume; 84443 ranks #68 of 19722 with the same characterization, and 85025 ranks #74 of 32833 and is labeled an extreme outlier). Those high national percentiles indicate the provider operates at volumes far above typical peers for core outpatient lab tests.
Within its state Medicaid market the provider shows dominant positions for several molecular and panel codes: 0240U ranks #1 of 10 in-state and is noted as notably above typical state volume, 87635 ranks #1 of 141 and is labeled an extreme outlier, while U0003 is also a top Medicaid revenue source. These in-state rankings imply the lab is a leading regional capacity for specific molecular assays and COVID-era testing workflows.
Several individual codes are flagged as statistical outliers or unusually high-volume for this provider, which speaks to operational scale: Medicare 85025 is an extreme outlier (100th percentile), Medicare 80053 and 84443 are noted as notably above typical national volume, and Medicaid 87635 and 0240U are described as extreme outlier or notably above typical state volume. Together these labels suggest this lab has invested in high-throughput platforms and specimen flow capable of sustaining very large volumes for select assays.
The practice has a long active footprint in claims data with an NPI enumerated 2007-03-09 (~19 years ago), supporting the interpretation that the observed high volumes and code mix reflect an established laboratory operation rather than a newly formed service. That tenure, combined with the mix of routine panels and high-volume molecular testing, is consistent with a mature clinical laboratory serving a broad outpatient population and public-health testing needs.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
291 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 45,390 | $10 | $453.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 25,900 | $20 | $414.4K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 40,500 | $10 | $324K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 22,640 | $10 | $294.3K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 6,960 | $30 | $201.7K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 18,730 | $10 | $168.5K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 4,990 | $20 | $89.8K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 9,810 | $10 | $78.4K |
| 0240U | N/A | 450 | $140 | $62.6K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 4,010 | $20 | $60.1K |
Showing 1–10 of 291
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 291 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
166 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 15,880 | $60 | $952.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 57,060 | $10 | $399.4K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 10,680 | $40 | $384.6K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 10,560 | $40 | $380.1K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 37,920 | $10 | $379.2K |
| 0240U | N/A | 3,040 | $110 | $346.3K |
| 0241U | N/A | 1,980 | $120 | $229.9K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 24,880 | $10 | $223.9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 10,910 | $20 | $218.3K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 5,080 | $40 | $208.2K |
Showing 1–10 of 166
How this provider's Medicaid billing volume and revenue compare to other Kansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kansas median
166 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 3 | 10 | 2,130 | $60 | $1.1M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 9 | 10 | 140 | $40 | $854.5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 5 | 50 | 300 | $60 | $648.3K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 3 | 10 | 1,000 | $50 | $385.6K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 4 | 20 | 120 | $20 | $375.6K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 3 | 10 | 150 | $60 | $331.2K |
| 80074 | The lab analyst performs an acute hepatitis panel; the panel must include tests for hepatitis A IgM antibody, hepatitis B core IgM antibody, hepatitis B surface antigen, and hepatitis C antibody. | 5 | 10 | 430 | $40 | $317.7K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 6 | 60 | 280 | $30 | $295.1K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 6 | 60 | 230 | $30 | $292K |
| 87522 | A lab tests a patient’s specimen to measure the amount of hepatitis C virus present. This may be referred to as viral load. | 3 | 10 | 450 | $30 | $281.3K |
Showing 1–10 of 166
Other providers in the same ZIP code as Cotton-o'neil Clinic Revocable Trust, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.